Twin Lakes Capital Management, LLC Amicus Therapeutics, Inc. Transaction History
Twin Lakes Capital Management, LLC
- $144 Million
- Q2 2024
A detailed history of Twin Lakes Capital Management, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Twin Lakes Capital Management, LLC holds 6,000 shares of FOLD stock, worth $68,820. This represents 0.04% of its overall portfolio holdings.
Number of Shares
6,000
Previous 6,000
-0.0%
Holding current value
$68,820
Previous $70,000
15.71%
% of portfolio
0.04%
Previous 0.05%
Shares
1 transactions
Others Institutions Holding FOLD
# of Institutions
282Shares Held
322MCall Options Held
260KPut Options Held
261K-
Vanguard Group Inc Valley Forge, PA28.6MShares$328 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$322 Million8.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY27.4MShares$314 Million3.71% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$280 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA21.1MShares$242 Million0.04% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $3.22B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...